IL214299A - Transdermal delivery systems of buprenorphine for use in treating pain - Google Patents

Transdermal delivery systems of buprenorphine for use in treating pain

Info

Publication number
IL214299A
IL214299A IL214299A IL21429911A IL214299A IL 214299 A IL214299 A IL 214299A IL 214299 A IL214299 A IL 214299A IL 21429911 A IL21429911 A IL 21429911A IL 214299 A IL214299 A IL 214299A
Authority
IL
Israel
Prior art keywords
buprenorphine
delivery systems
transdermal delivery
treating pain
pain
Prior art date
Application number
IL214299A
Other languages
Hebrew (he)
Other versions
IL214299A0 (en
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1998/003584 external-priority patent/WO1998036728A2/en
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of IL214299A0 publication Critical patent/IL214299A0/en
Publication of IL214299A publication Critical patent/IL214299A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
IL214299A 1997-02-24 2011-07-26 Transdermal delivery systems of buprenorphine for use in treating pain IL214299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3891997P 1997-02-24 1997-02-24
US93906897P 1997-09-29 1997-09-29
PCT/US1998/003584 WO1998036728A2 (en) 1997-02-24 1998-02-24 Sustained analgesia achieved with buprenorphine

Publications (2)

Publication Number Publication Date
IL214299A0 IL214299A0 (en) 2011-09-27
IL214299A true IL214299A (en) 2015-10-29

Family

ID=62788316

Family Applications (1)

Application Number Title Priority Date Filing Date
IL214299A IL214299A (en) 1997-02-24 2011-07-26 Transdermal delivery systems of buprenorphine for use in treating pain

Country Status (1)

Country Link
IL (1) IL214299A (en)

Also Published As

Publication number Publication date
IL214299A0 (en) 2011-09-27

Similar Documents

Publication Publication Date Title
EP0956091A4 (en) Iontophoretic drug delivery apparatus and method for use
AU7696098A (en) Substance p inhibitors in combination with nmda-blockers for treating pain
AU7245898A (en) Methods and devices for delivering opioid analgesics to wounds
IL120943A0 (en) Transdermal delivery system
PL335194A1 (en) Arylsulphonamides and their analogues as well as their application in treating neurodegenerative affections
ZA973277B (en) Freeze-dried liposome delivery system for application of skin treatment agents
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
EP0915716A4 (en) Systems and methods for delivering therapeutic agents to selected sites in a subject
IL127189A0 (en) Compositions methods and devices for the transdermal delivery of drugs
PL337888A1 (en) Imidazoprimidines and imidazopyridines for use in treating neurological disorders
EP0874828A4 (en) Composition for treating pain
AP9801175A0 (en) Quinoline and quinoline compounds useful in therapy
PL345216A1 (en) Methods and transdermal compositions for pain relief
HUP0002030A3 (en) Use of glur5 receptorantagonists for the treatment of pain
IL149655A0 (en) Improved transdermal contraceptive delivery system and process
ZA977745B (en) Transdermal delivery of peptides
ZA200007751B (en) Transdermal therapeutic system containing hormones and chrystallization inhibitors.
HUP9901434A3 (en) Substituted benzylamines and their use for the preparation of medicaments for treating depression
ZA9670B (en) Composition and methods for transdermal delivery of acid-lability drugs
AU6242498A (en) Methods for treating central and peripheral nerve pain
GB9809448D0 (en) Treatment device and method
IL214299A0 (en) Transdermal delivery systems of buprenorphine for use in treating pain
IL124419A0 (en) Composition for treating pain
HUP9802299A3 (en) Transdermal device for the delivery of alfuzosin
EP1007041A4 (en) Composition for treating pain

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
EXP Patent expired